Drug Profile
Research programme: lysosphingolipid receptor agonists - Amgen/EPIX
Alternative Names: AMG 277; PRX-13038; S1P1 agonists - EPIXLatest Information Update: 07 Oct 2011
Price :
$50
*
At a glance
- Originator EPIX Pharmaceuticals
- Developer Amgen; EPIX Pharmaceuticals
- Class
- Mechanism of Action Lysosphingolipid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Autoimmune disorders; Cancer